# Docosahexaenoic Acid (DHA) Supplementation in High Risk Pregnancies

> **NCT04069195** · NA · UNKNOWN · sponsor: **Walter Reed National Military Medical Center** · enrollment: 210 (estimated)

## Conditions studied

- Inflammation
- Pregnancy Related

## Interventions

- **DIETARY_SUPPLEMENT:** DHA supplement
- **DIETARY_SUPPLEMENT:** Corn Oil: Soybean Oil

## Key facts

- **NCT ID:** NCT04069195
- **Lead sponsor:** Walter Reed National Military Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04069195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04069195, "Docosahexaenoic Acid (DHA) Supplementation in High Risk Pregnancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04069195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*